Results 121 to 130 of about 34,607 (204)

Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection

Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes in patients with chronic hepatitis B virus (HBV) infection based on studies predominantly in Asian populations. We assessed real‐world associations between HBsAg loss and long‐term clinical outcomes in a diverse US population with chronic HBV infection. This
Myriam Drysdale, Rose Chang, Shuang Wang, Anna Coutinho, Vera Gielen, Theo Man, Rui Song, Mei Sheng Duh, Mandana Khalili, Dickens Theodore   +9 more
wiley   +1 more source

Seroprevalence and Risk Factors for Hepatitis E Virus in a Metropolis of Northeastern Brazil: A Population‐Based Survey

Zoonoses and Public Health, Volume 73, Issue 4, Page 326-335, June 2026.
ABSTRACT Introduction Hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide. While traditionally linked to poor sanitation in endemic areas, evidence shows increasing circulation in developed settings. In Brazil, however, population‐based data remain limited.
Carolline A. Mariz, Cynthia Braga, Wayner V. Souza, Carlos F. Luna, André Luiz Sá de Oliveira, Elisa de Almeida Neves de Azevedo, Clarice N. L. de Morais, Maria de Fatima P. M. Albuquerque, Edmundo Pessoa Lopes   +8 more
wiley   +1 more source

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review. [PDF]

J Virus Erad, 2023
Debrabander Q, Hensley KS, Psomas CK, Bramer W, Mahmoudi T, van Welzen BJ, Verbon A, Rokx C.   +7 more
europepmc   +1 more source

Effect of high dose vitamin D₃ on the HIV-1 reservoir: A pilot randomised controlled trial. [PDF]

J Virus Erad, 2023
Pitman MC, Meagher N, Price DJ, Rhodes A, Chang JJ, Scher B, Allan B, Street A, McMahon JH, Rasmussen TA, Cameron PU, Hoy JF, Kent SJ, Lewin SR.   +13 more
europepmc   +1 more source

Targeted plasma proteomics identifies MICA and IL1R1 proteins associated with HIV-1 reservoir size. [PDF]

iScience, 2023
Blaauw MJT, Cristina Dos Santos J, Vadaq N, Trypsteen W, van der Heijden W, Groenendijk A, Zhang Z, Li Y, de Mast Q, Netea MG, Joosten LAB, Vandekerckhove L, van der Ven A, Matzaraki V.   +13 more
europepmc   +1 more source

HIV-1 reservoir evolution in infants infected with clade C from Mozambique. [PDF]

Int J Infect Dis, 2023
Koofhethile CK, Rinaldi S, Rassadkina Y, Dinh VB, Gao C, Pallikkuth S, Garcia-Broncano P, de Armas LR, Pahwa R, Cotugno N, Vaz P, Lain MG, Palma P, Yu XG, Shapiro R, Pahwa S, Lichterfeld M.   +16 more
europepmc   +1 more source

HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies. [PDF]

Curr HIV/AIDS Rep, 2022
Kreider EF, Bar KJ.
europepmc   +1 more source

Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. [PDF]

Cell Host Microbe, 2023
Lian X, Seiger KW, Parsons EM, Gao C, Sun W, Gladkov GT, Roseto IC, Einkauf KB, Osborn MR, Chevalier JM, Jiang C, Blackmer J, Carrington M, Rosenberg ES, Lederman MM, McMahon DK, Bosch RJ, Jacobson JM, Gandhi RT, Peluso MJ, Chun TW, Deeks SG, Yu XG, Lichterfeld M.   +23 more
europepmc   +1 more source

Changes in HIV-1 Reservoir Dynamics After Mpox Infection. [PDF]

J Med Virol
Casado-Fernández G, de la Calle-Jiménez O, Armenteros I, Lemus Aguilar L, Fuertes D, Cantón J, Mateos E, Cabello N, Rodríguez Añover J, Negredo A, Cervero M, Sánchez Seco MP, Torres M, Estrada V, Coiras M.   +14 more
europepmc   +1 more source

TCR-mimic bispecific antibodies to target the HIV-1 reservoir. [PDF]

Proc Natl Acad Sci U S A, 2022
Sengupta S, Board NL, Wu F, Moskovljevic M, Douglass J, Zhang J, Reinhold BR, Duke-Cohan J, Yu J, Reed MC, Tabdili Y, Azurmendi A, Fray EJ, Zhang H, Hsiue EH, Jenike K, Ho YC, Gabelli SB, Kinzler KW, Vogelstein B, Zhou S, Siliciano JD, Sadegh-Nasseri S, Reinherz EL, Siliciano RF.   +24 more
europepmc   +1 more source